These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

870 related articles for article (PubMed ID: 33776917)

  • 1. The Centrality of Obesity in the Course of Severe COVID-19.
    Liu D; Zhang T; Wang Y; Xia L
    Front Endocrinol (Lausanne); 2021; 12():620566. PubMed ID: 33776917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes, obesity and COVID-19: A complex interplay.
    Vas P; Hopkins D; Feher M; Rubino F; B Whyte M
    Diabetes Obes Metab; 2020 Oct; 22(10):1892-1896. PubMed ID: 32627299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19).
    Zhou Y; Chi J; Lv W; Wang Y
    Diabetes Metab Res Rev; 2021 Feb; 37(2):e3377. PubMed ID: 32588943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
    Yin T; Li Y; Ying Y; Luo Z
    BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis.
    Singh AK; Gillies CL; Singh R; Singh A; Chudasama Y; Coles B; Seidu S; Zaccardi F; Davies MJ; Khunti K
    Diabetes Obes Metab; 2020 Oct; 22(10):1915-1924. PubMed ID: 32573903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes and covid-19: more than the sum of two morbidities.
    Pititto BA; Ferreira SRG
    Rev Saude Publica; 2020; 54():54. PubMed ID: 32491053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of obesity on COVID-19 patients.
    Yu W; Rohli KE; Yang S; Jia P
    J Diabetes Complications; 2021 Mar; 35(3):107817. PubMed ID: 33358523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course.
    Landstra CP; de Koning EJP
    Front Endocrinol (Lausanne); 2021; 12():649525. PubMed ID: 34220706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for Covid-19 severity and fatality: a structured literature review.
    Wolff D; Nee S; Hickey NS; Marschollek M
    Infection; 2021 Feb; 49(1):15-28. PubMed ID: 32860214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sympathetic activation: a potential link between comorbidities and COVID-19.
    Porzionato A; Emmi A; Barbon S; Boscolo-Berto R; Stecco C; Stocco E; Macchi V; De Caro R
    FEBS J; 2020 Sep; 287(17):3681-3688. PubMed ID: 32779891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunometabolic Dysregulation at the Intersection of Obesity and COVID-19.
    Khwatenge CN; Pate M; Miller LC; Sang Y
    Front Immunol; 2021; 12():732913. PubMed ID: 34737743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health Conditions Associated With Severe Illness From COVID-19 Among Individuals With Serious Mental Illness.
    Novak P; Sanmartin MX; Ali MM; Chen J
    Psychiatr Serv; 2021 Apr; 72(4):468-469. PubMed ID: 33208029
    [No Abstract]   [Full Text] [Related]  

  • 13. The Clinical Characteristics and Risk Factors of Severe COVID-19.
    Hu J; Wang Y
    Gerontology; 2021; 67(3):255-266. PubMed ID: 33406518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Nutrition in COVID-19 Susceptibility and Severity of Disease: A Systematic Review.
    James PT; Ali Z; Armitage AE; Bonell A; Cerami C; Drakesmith H; Jobe M; Jones KS; Liew Z; Moore SE; Morales-Berstein F; Nabwera HM; Nadjm B; Pasricha SR; Scheelbeek P; Silver MJ; Teh MR; Prentice AM
    J Nutr; 2021 Jul; 151(7):1854-1878. PubMed ID: 33982105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Presentation of Iranian Patients Affected with COVID-19: A Thousand Faces Disease.
    Mostafaei A; Ghojazadeh M; Hajebrahimi S; Abolhasanpour N; Salehi-Pourmehr H
    Iran J Allergy Asthma Immunol; 2021 Apr; 20(2):140-146. PubMed ID: 33904672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients.
    Dorjee K; Kim H; Bonomo E; Dolma R
    PLoS One; 2020; 15(12):e0243191. PubMed ID: 33284825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Overview on COVID-19 and its Effect on Cardiovascular Diseases.
    Hamadi A; Mahzari A; Hakami A; Hindawi S; Dobie G; Sayyed MI; Hamdi F; Nahari M; Jackson DE
    Endocr Metab Immune Disord Drug Targets; 2021; 21(11):1949-1953. PubMed ID: 33371840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First results of the "Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)".
    Jakob CEM; Borgmann S; Duygu F; Behrends U; Hower M; Merle U; Friedrichs A; Tometten L; Hanses F; Jung N; Rieg S; Wille K; Grüner B; Klinker H; Gersbacher-Runge N; Hellwig K; Eberwein L; Dolff S; Rauschning D; von Bergwelt-Baildon M; Lanznaster J; Strauß R; Trauth J; de With K; Ruethrich M; Lueck C; Nattermann J; Tscharntke L; Pilgram L; Fuhrmann S; Classen A; Stecher M; Schons M; Spinner C; Vehreschild JJ
    Infection; 2021 Feb; 49(1):63-73. PubMed ID: 33001409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global pandemics interconnected - obesity, impaired metabolic health and COVID-19.
    Stefan N; Birkenfeld AL; Schulze MB
    Nat Rev Endocrinol; 2021 Mar; 17(3):135-149. PubMed ID: 33479538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.